New ISR Report Offers Visibility into CRO Service Quality for Phase I Clinical Trials

Informing the drug development and commercialization industry Cary, N.C. – August 23, 2013 – Industry Standard Research (ISR) today announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase I Service Providers” providing the most comprehensive assessment of Phase I clinical research organization (CRO) service quality ever released. “ISR’s report provides … Continued

New ISR Report: Enhancing Relationships, Patient Recruitment with Patient Advocacy Groups

Informing the drug development and commercialization industry Cary, N.C. – July 26, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Advocacy Groups: Enhancing Relationships and Patient Recruitment.” For the report, ISR interviewed senior decision-makers from ten prominent patient advocacy groups to provide never before seen qualitative … Continued

ISR Report: Expecting Growth in Demand for Bioanalytical Lab Services through 2015

Informing the drug development and commercialization industry Cary, N.C. – July 17, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Bioanalytical Labs: Market Dynamics and Service Provider Performance.” The report provides the underserved industry with valuable market insights into the current and future demand for bioanalytical … Continued

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

Informing the drug development and commercialization industry Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in South Korea, sponsor and service provider activities in the region, as well … Continued

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364

ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records

Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides the pharmaceutical industry and its service providers with novel insights into the current and future … Continued

ISR’s Liver Cancer Market Report Shows Opportunity for Innovative Sponsors

Informing the drug development and commercialization industry Cary, N.C. – June 6, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Liver Cancer: Disease and Pipeline Analysis,” providing the pharmaceutical industry with a therapeutic assessment, pipeline analysis, and unique insight into the current clinical trial environment for … Continued

New ISR Phase I Report Shows Rise in Study Complexity and Use of Patient Populations

Informing the drug development and commercialization industry Cary, N.C. – May 15, 2012 – Industry Standard Research (ISR) today announced the release of a new market research report titled “2013 Phase I Study Trends and Market Outlook” providing the pharmaceutical industry and its service providers with new insights into phase-specific trends affecting in-house and outsourced … Continued

ISR’s Risk-based Monitoring Report Offers Industry Peer-based Guidance

Informing the drug development and commercialization industry Cary, N.C. – May 9, 2013 – Industry Standard Research (ISR) released a new market research report today entitled “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing.” The report was developed by surveying industry professionals with direct risk-based monitoring (RBM) experience and provides the pharmaceutical industry and … Continued

ISR’s CRO Quality Benchmarking Study Reports DCRI Staff among the Top

Informing the drug development and commercialization industry Cary, N.C. – April 23, 2012 – Industry Standard Research (ISR) announced the launch of its 5th annual CRO Quality Benchmarking series with today’s release of its “2013 CRO Quality Benchmarking – Phase II/III Service Providers” report.  The new study surveyed 157 pharmaceutical and biotechnology professionals about their … Continued

ISR Report Provides Medical Device Industry with Analysis of Historical Trials, Development Market Size, and Manufacturer Profiles

Informing the drug development and commercialization industry Cary, N.C. – April 3, 2013 – Industry Standard Research (ISR) announced the release of a new market research report entitled “Medical Device: Clinical Development Market Assessment,” which provides the medical device industry and its service providers with a new resource for their clinical development activities. “The medical … Continued

What Does the Future Hold for Clinical Monitoring?

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “What Does the Future Hold for Clinical Monitoring?” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=810203

ISR Report Provides Insight into Pancreatic Cancer, Clinical Development Pipeline

Informing the drug development and commercialization industry Cary, N.C. – March 27, 2013 – Industry Standard Research (ISR) today announced the release of a new pharmaceutical market research report entitled “Pancreatic Cancer: Disease and Pipeline Analysis” which provides insight into a market with few effective therapies. “ISR’s latest report profiles the pancreatic cancer market because … Continued

ISR in the News: 2013 Late Phase Market Overview and Outlook

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reports-Breaks-Down-2013-Late-Phase-Market-Ove/ArticleStandard/Article/detail/807543

Influence of Cost in the CRO Selection Process

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Influence of Cost in the CRO Selection Process” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Influence-of-Cost-in-the-CRO-Selection-Process/ArticleStandard/Article/detail/808507

ISR Report Shows Late Phase Study Conduct, Outsourcing Continues to Rise

Informing the drug development and commercialization industry Cary, N.C. – February 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market report titled “2013 Late Phase Market Overview and Outlook” which provides the pharmaceutical industry and its service providers with new insights into this rapidly growing segment of clinical trials. … Continued

ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “ISR’s ‘Social Media: Best Practices and Strategic Use in Patient Recruitment’” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISRs-Social-Media-Best-Practices-and-Strategic-Use/ArticleStandard/Article/detail/802212

ISR’s Report Offers Social Media Best Practices for Clinical Trial Patient Recruitment

Informing the drug development and commercialization industry. Cary, N.C. – January 8, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Social Media: Best Practices and Strategic Use in Patient Recruitment,” which will provide the pharmaceutical sponsors and patient recruitment service providers with new insights into the … Continued

ISR CUSTOMERS